Document is current
Any future updates will be listed below
-
Authors
Pérez-Escurza, Oihane https://orcid.org/0000-0002-6966-4337
Flores-Montero, Juan https://orcid.org/0000-0002-1119-4387
Óskarsson, Jón Þórir https://orcid.org/0000-0002-9201-1166
Sanoja-Flores, Luzalba https://orcid.org/0000-0002-9275-7793
Pozo, Julio
Lécrevisse, Quentin https://orcid.org/0000-0001-8715-5846
Martín, Silvia
Reed, Elín Ruth
Hákonardóttir, Guðlaug Katrín
Harding, Stephen
Þorsteinsdóttir, Sigrún https://orcid.org/0000-0001-5017-3530
Rögnvaldsson, Sæmundur https://orcid.org/0000-0003-2162-8414
Love, Thorvardur Jon
Durie, Brian
Kristinsson, Sigurdur Yngvi https://orcid.org/0000-0002-4964-7476
Orfao, Alberto https://orcid.org/0000-0002-0007-7230
,
- License Information
-
More Information
Article History
Received: 2 January 2025
Revised: 19 February 2025
Accepted: 11 March 2025
First Online: 27 March 2025
Competing interests
: SR, honoraria for scientific talks from Siemens Healthineers, Johnson & Johnson. ST, honoraria for scientific talks from Abbvie, Thermo Fisher. SYK, research funding from Amgen and Celgene; Independent Data Monitoring Committee for Jansen.
: Written informed consent was given by each donor according to the Declaration of Helsinki. The study was approved by the National Bioethics Committee (NCT03327597) and the Icelandic Data Protection Agency; the Spanish Ministry of Health granted permission (Registration number: 2020/252) for the transfer of the biological samples.
